Authors
Nicolas Molnarfi, Ulf Schulze-Topphoff, Martin S Weber, Juan C Patarroyo, Thomas Prod’homme, Michel Varrin-Doyer, Aparna Shetty, Christopher Linington, Anthony J Slavin, Juan Hidalgo, Dieter E Jenne, Hartmut Wekerle, Raymond A Sobel, Claude CA Bernard, Mark J Shlomchik, Scott S Zamvil
Publication date
2013/12/16
Journal
Journal of Experimental Medicine
Volume
210
Issue
13
Pages
2921-2937
Publisher
The Rockefeller University Press
Description
Whether B cells serve as antigen-presenting cells (APCs) for activation of pathogenic T cells in the multiple sclerosis model experimental autoimmune encephalomyelitis (EAE) is unclear. To evaluate their role as APCs, we engineered mice selectively deficient in MHC II on B cells (B–MHC II−/−), and to distinguish this function from antibody production, we created transgenic (Tg) mice that express the myelin oligodendrocyte glycoprotein (MOG)–specific B cell receptor (BCR; IgHMOG-mem) but cannot secrete antibodies. B–MHC II−/− mice were resistant to EAE induced by recombinant human MOG (rhMOG), a T cell– and B cell–dependent autoantigen, and exhibited diminished Th1 and Th17 responses, suggesting a role for B cell APC function. In comparison, selective B cell IL-6 deficiency reduced EAE susceptibility and Th17 responses alone. Administration of MOG-specific antibodies only partially restored EAE …
Total citations
201420152016201720182019202020212022202320242854434329424764374117